Denosumab vs Zoledronic Acid for Bone-Targeted Therapy in Multiple Myeloma
Author:
Affiliation:
1. Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio
2. Multiple Myeloma Program, Cleveland Clinic, Cleveland, Ohio
Publisher
American Medical Association (AMA)
Subject
Oncology,Cancer Research
Link
https://jamanetwork.com/journals/jamaoncology/article-pdf/5/8/1095/17773704/jamaoncology_chakraborty_2019_vp_190008.pdf
Reference8 articles.
1. Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.;Raje;Lancet Oncol,2018
2. Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update.;Anderson;J Clin Oncol,2018
3. Bisphosphonates in multiple myeloma: an updated network meta-analysis.;Mhaskar;Cochrane Database Syst Rev,2017
4. Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid.;Vadhan-Raj;Ann Oncol,2012
5. Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension.;Cummings;J Bone Miner Res,2018
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dendrobine attenuates osteoclast differentiation through modulating ROS/NFATc1/ MMP9 pathway and prevents inflammatory bone destruction;Phytomedicine;2022-02
2. Spatiotemporally controlled calcitonin delivery: Long-term and targeted therapy of skeletal diseases;Journal of Controlled Release;2021-10
3. Treatment and disease‐related complications in multiple myeloma: Implications for survivorship;American Journal of Hematology;2020-03-13
4. Use of Bone-Modifying Agents Among Medicare Beneficiaries With Multiple Myeloma;JAMA Oncology;2020-02-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3